News
Global Cannabis News & Analysis | Business of Cannabis
News · page 5
- UK & Europe
New Report: Germany’s Cannabis Market Crosses €1.15bn as Reimbursement Era Ends
Germany’s medical cannabis market reached approximately €1.15bn in 2026, with private self-pay prescriptions now generating around 75% of total market value, according to a new whitepaper published today by Business of Cannabis and Prohibition Partners.
- M&A Activity
Argent Biopharma’s CannEpil to Target $3bn Veterinary Pain Market, Weeks After Debt-Relief Deal
Argent Biopharma’s (RGT) flagship CannEpil cannabis drug is set to pivot into the veterinary market, just weeks after it signed away the commercial rights in exchange for debt relief.
- Clinical Research
The science of THCV
Cannabis research has historically concentrated on THC and CBD, and for good reason.
- Adult-Use
Thailand Presses Medical-Only Cannabis Bill Toward Cabinet as Enforcement Drive Widens
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
- Hemp Industry
US Hemp Industry Wins a Stay of Execution as Senate Delays Ban Until December
The US hemp industry has successfully bought itself some additional time to find a permanent solution to the incoming federal ban.
- Interviews
Cannabis Opportunity ‘Greater Today’ Than in 2019, Says the Lender Who Has Committed $550m
Just over a month ago, one of the most interesting and potentially consequential hearings in the history of US cannabis policy began.
- UK & Europe
Spain’s Tobacco Crackdown Could Quietly Wipe Out Its Cannabis Clubs
Last week, Spain’s government approved a draft tobacco law that never once mentions cannabis, yet could dismantle the everyday activity of the country’s thriving cannabis social clubs.
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- Prescribers & Clinics
The Human Side of Hypergrowth: Recruitment, Culture and Maintaining Standards at Releaf
The UK has another new Prime Minister, Andy Burnham, who has wasted no time in laying out his plans to fundamentally reform the country’s creaking healthcare infrastructure.
- Clinical Research
A Cannabis Flavonoid Stopped Up to 99% of Cancer-Cell Growth in Lab Tests
Standard Seed Corporation (SSC), a cutting edge AI botanical-research company, believes it has identified a compound native to cannabis which could inhibit the growth of cancer cells by over 90% in some of the most aggressive forms of cancer.
- CBD Market
CBD Brand Director Sentenced for Covid Loan Fraud and Money Laundering
The director of UK CBD brand Virtutum Limited, which traded as CBD Asylum in Hull, has been given a suspended prison sentence for fraud and money laundering.
- Opinion
Opinion: New Labour Administration Can End Britain’s Failed Cannabis Experiment
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
